Renaissance Technologies LLC Raises Stock Position in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Renaissance Technologies LLC grew its holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 12.1% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 406,200 shares of the company’s stock after acquiring an additional 44,000 shares during the period. Renaissance Technologies LLC’s holdings in Stereotaxis were worth $926,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in STXS. Geode Capital Management LLC boosted its stake in shares of Stereotaxis by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 1,399,498 shares of the company’s stock worth $3,192,000 after purchasing an additional 7,780 shares during the period. State Street Corp boosted its stake in shares of Stereotaxis by 5.7% during the 3rd quarter. State Street Corp now owns 680,612 shares of the company’s stock worth $1,388,000 after purchasing an additional 36,518 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of Stereotaxis by 13.0% during the 4th quarter. Bank of New York Mellon Corp now owns 193,109 shares of the company’s stock worth $440,000 after purchasing an additional 22,280 shares during the period. Traynor Capital Management Inc. purchased a new position in shares of Stereotaxis during the 4th quarter worth about $366,000. Finally, JPMorgan Chase & Co. boosted its stake in shares of Stereotaxis by 463.8% during the 4th quarter. JPMorgan Chase & Co. now owns 134,822 shares of the company’s stock worth $307,000 after purchasing an additional 110,909 shares during the period. 45.35% of the stock is owned by hedge funds and other institutional investors.

Stereotaxis Trading Down 1.0 %

STXS stock opened at $2.00 on Thursday. Stereotaxis, Inc. has a 12 month low of $1.54 and a 12 month high of $2.72. The company has a 50-day moving average price of $1.90 and a 200 day moving average price of $2.07. The stock has a market cap of $169.46 million, a PE ratio of -7.14 and a beta of 1.54.

Insider Buying and Selling

In related news, Director Paul J. Isaac acquired 38,000 shares of the stock in a transaction on Monday, March 10th. The stock was bought at an average cost of $1.81 per share, with a total value of $68,780.00. Following the transaction, the director now directly owns 87,299 shares in the company, valued at approximately $158,011.19. This represents a 77.08 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. 18.52% of the stock is owned by corporate insiders.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.